Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Schwarz

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2018
The impact of [<sup>68</sup>Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancerThorsten Frenzel, Milena Tienken, Merve Abel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Seminars in Thrombosis and Hemostasis|May 23, 2002
Sixteen years of treatment with pasteurized human clotting factor concentrates in children and adolescents: a pharmacosurveillance investigation comprising 727 patient yearsWolfgang Muntean, Werner Zenz, Jutta Falger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2018
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancerAnastassia Löser, Burkhard Beyer, Cedric Oliver Carl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 27, 2004
Emergency localization of radioactive seeds lost during intracoronary brachytherapyAndreas Krüll, Ralf Köster, Karl Heinz Bohuslavizki, et al.
Urologic Oncology|November 26, 2015
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancerKatharina Boehm, Jonas Schiffmann, Zhe Tian, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 5, 2014
Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapyJonas Schiffmann, Hans Lesmana, Pierre Tennstedt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2021
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional studyCarmen Escuriola Ettingshausen, Olga Katsarou, Barbara Faganel Kotnik, et al.
Journal of Endourology|October 24, 2013
Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms--a retrospective feasibility studyAndreas Becker, Anne Placke, Luis Kluth, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2018
The impact of [<sup>68</sup>Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancerThorsten Frenzel, Milena Tienken, Merve Abel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Seminars in Thrombosis and Hemostasis|May 23, 2002
Sixteen years of treatment with pasteurized human clotting factor concentrates in children and adolescents: a pharmacosurveillance investigation comprising 727 patient yearsWolfgang Muntean, Werner Zenz, Jutta Falger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2018
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancerAnastassia Löser, Burkhard Beyer, Cedric Oliver Carl, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 27, 2004
Emergency localization of radioactive seeds lost during intracoronary brachytherapyAndreas Krüll, Ralf Köster, Karl Heinz Bohuslavizki, et al.
Urologic Oncology|November 26, 2015
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancerKatharina Boehm, Jonas Schiffmann, Zhe Tian, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 5, 2014
Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapyJonas Schiffmann, Hans Lesmana, Pierre Tennstedt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2021
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional studyCarmen Escuriola Ettingshausen, Olga Katsarou, Barbara Faganel Kotnik, et al.
Journal of Endourology|October 24, 2013
Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms--a retrospective feasibility studyAndreas Becker, Anne Placke, Luis Kluth, et al.
Pageof 6